Type 2 Diabetes

Developing Type 2 diabetes in childhood or adolescence carries a greater risk for complications and death than for those who develop the disease in middle age

Subcutaneous insulin infusion is the gold standard for type 1 diabetic therapy, but this approach may induce glycemic variability in some patients.

Delayed-release metformin designed to target the lower intestine with reduced absorption into the blood leads to similar glucose-lowering effects, but at a lower dose and reduced systemic exposure.

If your diabetic patients are feeling a pinch in their pockets, insulin costs may be to blame.

New prefilled and reusable insulin delivery devices will require education and training for patients, significant others, and caregivers.

As one of the components of the CHADS2 score diabetes is a known risk for stroke. A recent study looked at how rivaroxaban, also known as Xarelto can help patients reduce this potentially deadly health issue.

You’ve heard it time and time again: eat breakfast. But this practice may be particularly beneficial in people with type 2 diabetes – but not just any breakfast.

Do patients expect more from doctors who counsel lifestyle modification? What degree of importance do you place on setting a healthy example?

Only a handful of medications carry an FDA indication for obesity, but metformin (which currently does not) has weighty evidence supporting its use.

Animal studies have shown melatonin reduces body weight, plasma leptin, adiponectin, triglycerides, cholesterol, insulin, and glucose levels beyond its effects on circadian rhythm.

Low-dose weekly chloroquine is lipid modulating, although to a smaller extent than high-dose therapy. Study results suggest that low-dose chloroquine is an inexpensive and well-tolerated agent for dyslipidemia patients.

Half of diabetic patients experience diabetic neuropathies, and the total number of cases will increase annually alongside the ever-increasing diabetes incidence rate.

Researchers report that St. John’s Wort produces persistent glucose intolerance via decreased beta-cell function. St. John’s Wort may increase risk of type 2 diabetes in the already at-risk depressed population.

Clinical trials have shown that GLP-1 RAs reduce HbA1c and weight in type 2 diabetes, but are these outcomes confounded by concomitant medications?

A meta-analysis examined the effect of treatment with a GLP-1 receptor agonist on cardiovascular event risk in type 2 diabetes patients.

Recent findings show a link between obstructive sleep apnea (OSA) & type 2 diabetes. A new study examines cortisol levels & glucose metabolism in OSA.

Two recent studies examined the link between depressive symptoms in adolescence and type 2 diabetes.

Treating a rare genetic form of diabetes with oral medications may do more harm than good.

Treating diabetes in the frail elderly may require different treatment goals.

There’s bad news for people with diabetes who use continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea. Contrary to some previous reports, CPAP will not boost diabetes control.

Antigen mimicry may become an effective strategy in preventing type 1 diabetes.

The diabetes epidemic has been developing for decades and it will likely take that long if not longer to reverse this trend but there is work being done on several fronts to help future generations not have to deal with this as such a common condition.

There may not be as many treatment options available for patients with type 1 diabetes but there are still good choices to give them a high quality of life. As the development of the artificial pancreas moves along another even better option is just out of reach.

There is no shortage of patients with type 2 diabetes and an equally large number of treatment options available. However, matching the patients to the correct treatment option remains a challenge for endocrinologists and those in the health care community.

When looking to reduce gestational diabetes risk, do lifestyle interventions work? Is it better to focus on diet, exercise, or both?

What drives you to embrace the challenges, frustrations, and triumphs of helping your patients battle diabetes?

Are diabetic patients at an increased risk of infection with community-acquired Staphylococcus aureus? If so, can risks be mitigated?

New data suggest overly intensive blood pressure treatment in diabetics could lead to worse CV outcomes. How should you set goals for your patients?

Working in the field of diabetes there has been a considerable amount of progress made, but there is still a long way to go in patient care.

One of the best ways to treat diabetes is to prevent it from developing in the first place. With the number of patients far outweighing the number of doctors that daunting task can be easier said than done.